Peyote produces intense visual hallucinations, altered perception of time, and changes in mood and thought patterns that last roughly 8 to 12 hours. Its primary active compound, mescaline, works by binding to serotonin receptors in the brain, triggering a long, slow psychedelic experience that differs from other hallucinogens in both duration and character. The experience also comes with significant physical effects, most notably nausea and vomiting that can begin within 30 minutes of ingestion.
How Mescaline Works in the Brain
Mescaline, the psychoactive compound in peyote, has a phenylethylamine structure (the same chemical family as dopamine) and primarily activates serotonin 5-HT2A receptors. These are the same receptors targeted by psilocybin and LSD, which is why the three substances produce overlapping effects. However, mescaline also binds to several other serotonin receptor subtypes, including 5-HT1A, 5-HT2B, and 5-HT2C. Research in rats has confirmed that the 5-HT2A receptor is the main driver of mescaline’s psychedelic effects, with smaller contributions from the 5-HT2C receptor.
Mescaline is considerably less potent than other naturally occurring psychedelics, roughly 30 times weaker than psilocybin by weight. A full psychoactive dose requires 200 to 500 milligrams of pure mescaline, which translates to eating several dried peyote buttons (the small, disc-shaped tops of the cactus). This large dose of plant material is one reason the experience starts with so much gastrointestinal discomfort.
Timeline From Ingestion to Comedown
Peyote’s effects unfold in a slow, layered sequence. Within 30 minutes of eating the cactus, you can expect nausea, sweating, a rapid heartbeat, and sometimes trembling. Vomiting is common during this early window and is partly caused by the intensely bitter alkaloids in the cactus flesh.
The psychological effects begin creeping in around 30 to 60 minutes, but the full psychedelic experience doesn’t peak until 1 to 2 hours after ingestion. This peak involves the most vivid hallucinations and the strongest shifts in perception. From there, the sensory phase lasts at least 6 hours, and the total experience can stretch to 8 hours or longer. A systematic review across multiple studies found that mescaline’s effects persist for an average of about 11 hours, making it longer-lasting than both psilocybin (roughly 5 hours) and LSD (roughly 8 hours).
What the Experience Feels Like
Peyote hallucinations are primarily visual. Users commonly report geometric patterns: spirals, funnels, cones, honeycomb shapes, and kaleidoscopic imagery that shifts and morphs. These aren’t typically full-scene hallucinations where you see things that aren’t there. They’re more like distortions layered on top of what you’re already seeing, with colors becoming dramatically more vivid and surfaces appearing to breathe or ripple.
Auditory effects are less common but do occur. Some users describe hearing a guiding voice, sometimes characterized as a teacher-like presence. Synesthesia, where senses cross over so that you “hear” colors or “see” sounds, has been reported with mescaline-class psychedelics. Time perception warps significantly. Minutes can feel like hours, and the boundaries between past, present, and anticipated future can blur.
In clinical settings, a Bayesian analysis of over 200 participants found that about 31% experienced a sense of well-being, while roughly 19% reported anxiety or agitation. About 5% experienced paranoia or psychotic-like symptoms. Notably, 45% reported no significant psychological change, suggesting the experience varies widely from person to person. Context and expectations appear to play a major role in shaping the outcome.
Physical Effects on the Body
Peyote raises your heart rate, increases blood pressure, and dilates your pupils. Body temperature also rises. These effects are driven by mescaline’s stimulation of the sympathetic nervous system, the same system responsible for your fight-or-flight response. In clinical data, about 16% of participants experienced a noticeably elevated heart rate, while roughly 7% had measurable pupil dilation. Around 76% reported no adverse physical effects beyond the initial discomfort.
The nausea and vomiting deserve special attention because they’re so central to the peyote experience. The cactus contains dozens of alkaloids beyond mescaline, and its flesh is extremely bitter. Muscle tension, leg tremors, and a sensation of pressure in the chest or lungs have also been reported. Some users experience a temporary loss of appetite that can last beyond the psychoactive effects.
Nausea in Ceremonial Context
In Native American Church ceremonies and indigenous Mesoamerican practices, peyote-induced vomiting is not considered a side effect. It’s often treated as a meaningful part of the ritual, sometimes described as a spiritual purging. Peyote has been used in tribal ceremonies by indigenous cultures in North America for over 3,000 years, and these traditions frame the entire experience, including the physical discomfort, as part of the healing process. The ceremonial setting, the guided structure, and the community support all appear to influence how participants interpret what they’re going through.
Risks and Long-Term Concerns
The most commonly discussed long-term risk of any hallucinogen is Hallucinogen Persisting Perception Disorder, or HPPD, a condition where visual disturbances from the trip continue appearing days, weeks, or even years later. The DSM-5 estimates that about 4.2% of all hallucinogen users experience HPPD-like symptoms. Mescaline is listed among the substances that can trigger it, though LSD accounts for the largest share of reported cases (37%), followed by cannabis (13%) and MDMA (6%). Mescaline falls into a broader category of less frequently reported triggers.
When HPPD does develop, it tends to linger. Among documented cases, about 41% experienced symptoms lasting one month to a year, 30% lasted one to five years, and 16% persisted beyond five years. People with co-occurring depression or anxiety had longer symptom duration and worse treatment outcomes. About a third of all cases eventually achieved full remission.
Studies on long-term cognitive effects of peyote specifically are limited. Much of what we know comes from research on other classical psychedelics, and the available evidence doesn’t point to lasting cognitive impairment from occasional use. However, the existing literature on mescaline is small and variable in quality, making definitive conclusions difficult.
Early Therapeutic Research
Mescaline was one of the first psychedelics studied for therapeutic use, with most clinical trials conducted over 50 years ago. Those older studies reported improvements in depression symptoms, alcohol use, nicotine dependence, and obsessive thinking. A more recent Phase I study found that a single dose of mescaline was physically and psychologically safe in 48 healthy volunteers in a controlled setting, though the small sample size limits how much can be drawn from it.
The therapeutic research remains far behind what exists for psilocybin or MDMA. Most modern mescaline studies are survey-based or involve too few participants to produce strong conclusions. The evidence suggests potential relevance for mood disorders and substance dependence, but it’s nowhere near sufficient for clinical recommendations.
Legal Status
Mescaline is a Schedule I controlled substance in the United States, making peyote illegal for most people to possess, use, or transport. The major exception is sacramental use by members of the Native American Church. Under 42 U.S. Code ยง 1996a, the use, possession, or transportation of peyote by a member of a federally recognized Indian tribe for bona fide traditional ceremonial purposes is lawful and cannot be prohibited by any state or federal authority. Members also cannot be denied public assistance benefits or penalized in any way based on ceremonial peyote use. This protection applies specifically to enrolled members of recognized tribes practicing a traditional Indian religion.